Nagorney D M, Donohue J H, Farnell M B, Schleck C D, Ilstrup D M
Department of Gastroenterologic and General Surgery, Rochester, Minn.
Arch Surg. 1993 Aug;128(8):871-7; discussion 877-9. doi: 10.1001/archsurg.1993.01420200045008.
To elucidate the clinical and pathologic features of extrahepatic cholangiocarcinomas and to identify prognostic variables in patients treated surgically.
Retrospective review of clinical records of patients undergoing surgical exploration for cholangiocarcinoma, with univariate and multivariate analyses of the clinical and pathologic factors that influenced patient survival.
Mayo Clinic, Rochester, Minn.
One hundred seventy-one patients undergoing operative intervention for diagnostic, palliative, or curative reasons between 1976 and 1985. Follow-up was complete until death or for a minimum of 5 years for surviving patients.
A curative surgical resection was performed in 29% of patients, while the remainder underwent tumor biopsy or a palliative procedure.
Patient survival following operative treatment.
The operative mortality in this patient cohort was 5% and median survival was 13 months. Overall 5-year survival was 16%, with 44% of patients having a curative resection still alive at 5 years. Using univariate analysis, curative resection, tumor stage, Eastern Cooperative Oncology Group performance status, total bilirubin concentration, lymph node status, liver invasion, tumor morphology, tumor grade, and site of tumor origin were significant determinants of prognosis. Using the Cox proportional hazards model for multivariate analysis, curative resection, Eastern Cooperative Oncology Group performance status, total bilirubin concentration, and tumor grade were the only variables predictive of patient outcome. A curative resection of a proximal cholangiocarcinoma had a similar chance of providing long-term survival as a curative distal ductal resection.
Although the tumor extent and the patient's overall health will affect outcome, curative resection for cholangiocarcinoma at all sites should be undertaken since this treatment offers the best chance for long-term survival.
阐明肝外胆管癌的临床和病理特征,并确定手术治疗患者的预后变量。
对接受胆管癌手术探查患者的临床记录进行回顾性分析,对影响患者生存的临床和病理因素进行单因素和多因素分析。
明尼苏达州罗切斯特市梅奥诊所。
1976年至1985年间因诊断、姑息或治愈目的接受手术干预的171例患者。对存活患者的随访直至死亡或至少5年。
29%的患者接受了根治性手术切除,其余患者接受了肿瘤活检或姑息性手术。
手术治疗后的患者生存情况。
该患者队列的手术死亡率为5%,中位生存期为13个月。总体5年生存率为16%,44%接受根治性切除的患者在5年后仍存活。单因素分析显示,根治性切除、肿瘤分期、东部肿瘤协作组体能状态、总胆红素浓度、淋巴结状态、肝侵犯、肿瘤形态、肿瘤分级和肿瘤起源部位是预后的重要决定因素。多因素分析采用Cox比例风险模型,结果显示根治性切除、东部肿瘤协作组体能状态、总胆红素浓度和肿瘤分级是预测患者预后的唯一变量。近端胆管癌的根治性切除与远端胆管癌的根治性切除提供长期生存的机会相似。
尽管肿瘤范围和患者的整体健康状况会影响预后,但胆管癌各部位的根治性切除均应进行,因为这种治疗提供了长期生存的最佳机会。